Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
Source:http://linkedlifedata.com/resource/pubmed/id/7762497
Am. J. Cardiol.
1995
Jun
1
75
16
1120-3
